Process Industries · Chemicals: Agricultural · NSE: ARISTO · data 2026-10-09

Aristo Bio Tech and Lifescience Limited

Health check: Weak (2.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹94

Market cap

—

P/E

—

P/B

—

ROE

—

ROCE

—

Debt / equity

—

Dividend yield

—

1-year return

-22.6%

52-week high

₹135

52-week low

₹74.3

Operating margin

—

Growth

Revenue (last 12 months)	—
Net profit (last 12 months)	—
Sales growth, 3 years (yearly)	—
Profit growth, 3 years (yearly)	—

Similar companies

Crop Life Science Ltd. (CLSL) · Nagarjuna Fertilizers & Chemicals Ltd. (NAGAFERT) · Dhansa Labs Limited (DHANSA) · Agro Phos India Ltd. (AGROPHOS) · Bohra Industries Ltd. (BOHRAIND)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ARISTO in NSE Scanner →